Literature DB >> 21055814

Ocular tuberculosis: a clinicopathologic and molecular study.

Keith J Wroblewski1, Ahmed A Hidayat, Ron C Neafie, Narsing A Rao, Michael Zapor.   

Abstract

OBJECTIVE: To analyze the clinical profiles, histopathologic features, and Mycobacterium tuberculosis polymerase chain reaction testing in patients with ocular tuberculosis.
DESIGN: Retrospective case series. PARTICIPANTS: Forty-two patients.
METHODS: This retrospective study was approved by the Armed Forces Institute of Pathology (AFIP) Institutional Review Board. The AFIP data banks were screened for cases with diagnosis of ocular tuberculosis using key words such as mycobacterium; tuberculosis; and acid-fast bacilli. Files and slides stained with hematoxylin-eosin and acid-fast staining were reviewed by the Division of Ocular Pathology and by the Infectious Diseases and Parasitic Diseases Pathology Branches. When available; blocks and unstained slides were sent to the Doheny Eye Institute; Los Angeles; California; for quantitative polymerase chain reaction (qPCR) analysis to detect Mycobacterium tuberculosis-specific DNA. MAIN OUTCOME MEASURES: Tuberculin skin test (TST) results, as well as the chest radiograph results, were recorded. When acid-fast bacilli were identified in tissue, their locations-ocular or extraocular sites-were recorded. Emphasis was placed on lymph node involvement and any systemic diseases.
RESULTS: In the histopathologic specimens, microscopy revealed a paucity of organisms, and often there were only 1 or 2 organisms associated with or near a giant cell or near an area of necrosis. The qPCR analysis was performed on 6 biopsy specimens. These specimens showed necrotizing granulomatous inflammation from 6 different patients; 3 had positive qPCR results. In 2 of the 3 cases with positive qPCR results, acid-fast bacilli were not found in the tissue sections. In 17 patients, TST results were available; 10 had positive results (60%) and 7 had negative results (40%). Fourteen chest radiograph results were submitted, and 8 (57%) of 14 patients had normal chest films.
CONCLUSIONS: This study suggests that in dealing with those populations at increased risk of tuberculosis (e.g., immigrants from endemic areas and human immunodeficiency virus-infected patients) or patients receiving biologic therapy, the ophthalmologist should endeavor to entertain this diagnosis and to rely on the support of infectious disease specialists and pulmonologists to help solidify the diagnosis, because the current methods for the diagnosis have limited sensitivity.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055814     DOI: 10.1016/j.ophtha.2010.08.011

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  33 in total

1.  The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area.

Authors:  Jolly Tsui; Mary Ho; Grace Lui; Timothy Li; Lijia Chen; Lawrence Iu; Marten Brelen; Alvin L Young
Journal:  Int Ophthalmol       Date:  2021-05-26       Impact factor: 2.031

2.  Intraocular tuberculosis presenting as a large anterior chamber mass.

Authors:  Trucian A Ostheimer; James P Dunn; Charles G Eberhart; Bryn M Burkholder
Journal:  Ocul Immunol Inflamm       Date:  2014-04-25       Impact factor: 3.070

3.  Orbital tuberculosis presenting as proptosis and fever: the risk of empiric corticosteroids.

Authors:  Rodrigo de Carvalho Santana; Paulo Louzada; Valdes Roberto Bollela; Antonio Augusto Vellasco Cruz; Benedito Antonio Lopes da Fonseca
Journal:  Int Ophthalmol       Date:  2013-03-10       Impact factor: 2.031

4.  Tuberculosis and other causes of uveitis in Indonesia.

Authors:  R La Distia Nora; R Sitompul; M Bakker; M Susiyanti; L Edwar; S Sjamsoe; G Singh; M P van Hagen; A Rothova
Journal:  Eye (Lond)       Date:  2017-11-03       Impact factor: 3.775

5.  Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis.

Authors:  Sarah John; Oliver H Bell; Leslie Wilson; David A Copland; Kathryn L Pepple
Journal:  J Vis Exp       Date:  2021-12-17       Impact factor: 1.355

6.  Infectious Uveitis.

Authors:  Phoebe Lin
Journal:  Curr Ophthalmol Rep       Date:  2015-06-13

7.  Transcriptional signatures of Mycobacterium tuberculosis in mouse model of intraocular tuberculosis.

Authors:  Sudhanshu Abhishek; Michelle Beth Ryndak; Alpa Choudhary; Sumedha Sharma; Amod Gupta; Vishali Gupta; Nirbhai Singh; Suman Laal; Indu Verma
Journal:  Pathog Dis       Date:  2019-07-01       Impact factor: 3.166

8.  Detection of Mycobacterium tuberculosis with nested polymerase chain reaction analysis in enucleated eye ball in Eales' disease.

Authors:  Aditya Verma; Jyotirmay Biswas; L Dhanurekha; R Gayathri; K Lily Therese
Journal:  Int Ophthalmol       Date:  2015-10-24       Impact factor: 2.031

9.  Anti-TB monotherapy for choroidal tuberculoma: an observational study.

Authors:  Ashish Khalsa; Anup Kelgaonkar; Soumyava Basu
Journal:  Eye (Lond)       Date:  2021-04-01       Impact factor: 3.775

10.  A diagnostic dilemma: infectious versus noninfectious multifocal choroiditis with panuveitis.

Authors:  Sharel Ongchin; C Dirk Keene; Russell Van Gelder; Gurunadh Atma Vemulakonda
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.